The South and Central America biofilms treatment market is expected to reach US$ 330.62 million by 2027 from US$ 200.61 million in 2019. The market is estimated to grow with a CAGR of 6.5% from 2020 to 2027.
The growth of the South and Central America biofilms treatment market is driven by the rising prevalence of obesity and its comorbidities, and growing incidence of traumatic wounds across the region. However, problems associated with biofilms treatment is restricting the market growth.
Obesity contributes to inflammatory dermatologic conditions such as psoriasis and poor wound healing. Immobility is a risk factor for pressure ulcers in hospitalized patients. Obesity patients in the Intensive Care Unit (ICU) are immobile, and it gives subsequent pressure on skin surfaces. Obese patients require constant help to change their position in bed to relieve sites of increased skin pressure. An Argentinian survey revealed that 50.5% of the population exceeded expected healthy weights. Of these, 34.8% were overweight, and 14.8% were obese. Gender-wise statistics revealed that 40.3% of females and 59.7% of males were overweight. In Brazil, a study done by the Ministry of Health in 2011 showed that 48.1% of the population was either overweight (33.1%) or obese (15%). These figures were 22.7% and 11.4% in 2026, respectively. Thus, rising incidence of obesity increases the risk of pressure ulcers and poor wound healing. In Brazil, the System of Surveillance of Risk Factors and Protection against Chronic Diseases by Telephone Inquiry (VIGITEL) stated that the prevalence of diabetes has increased from 15 to 18% from 2010 to 2014. As per the Family Budget Survey (POF), the prevalence of obesity among men increased from 9.3% (2002–2003) to 12.7% (2008–2009); in women, it rose from 14.0 to 17.5% in the respective surveys. Obesity is closely related to various chronic diseases. The most significant risk is diabetes mellitus. In Brazil, the prevalence of diabetes in adults with average/low weight is 5.4%; in the population with obesity, it is more than double, i.e. 14.0%. Several studies have shown that obesity increases the risk of hypertension. Several types of cancer, such as colorectal cancer, also have a strong association with obesity. Thus, the rising prevalence of obesity and its comorbidities drives the growth of the South and Central America biofilms treatment market.
The COVID-19 pandemic is becoming the most significant challenge in South and Central America. Latin America is hit by the pandemic, and thus has profound humanitarian, economic, and political consequences. South and Central America are among the regions reporting rising number of COVID-19 cases. The increasing numbers of patients are becoming threats to their respective countries as they are facing economic crises, which is adversely affecting various sectors such as healthcare. The countries in this region are majorly dependent on the imported healthcare products. The lockdown in various countries across the world and the limitations on transport are declining the sales of healthcare products. All these factors are consequently restraining the growth of the South and Central America biofilms treatment market.
Based on product, the South and Central America biofilms treatment market is segmented into debridement equipment, gauzes and dressings, grafts and matrices, and others. In 2019, the gauzes and dressings segment held the largest market share. The same segment is anticipated to register the highest CAGR in the market during 2020–2027.
The South and Central America biofilms treatment market, based on wound, is segmented into traumatic and surgical wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others. The traumatic and surgical wounds segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period.
By end user, the South and Central America biofilms treatment market is segmented into hospitals, home care settings, and others. The hospitals segment held the largest market share in 2019; the same segment is anticipated to register the highest CAGR in the market from 2020 to 2027.
A few of the primary and secondary sources referred to while preparing the report on the South and Central America biofilms treatment market are the Argentine National Risk Factor Survey (ANRFS) and Uni?ed National Health System (SUS).